Didanosine
Product Images NDC 54868-5464

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Didanosine (NDC 54868-5464). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Didanosine Delayed-release Capsules 250 mg 30s Label (5464)

Didanosine DR 250 mg capsules packaging label by Physicians Total Care, Inc. The label includes the product name, strength (250 mg), dosage form (capsules), package count (30 capsules), lot number, expiration date (01/98), and a barcode. The label also lists the manufacturer as Bristol Laboratories, Inc.*

FDA Label Image

Chemical Structure (D24972e3 4394 41e2 8d20 4eac923fc3e9 01)

Chemical structure of Didanosine, showing its molecular diagram with atoms and bonds representing the nucleoside analog antiviral agent used in HIV treatment.*

FDA Label Image

Figure 1 (D24972e3 4394 41e2 8d20 4eac923fc3e9 02)

A line graph showing the percent of patients on the vertical axis and study week on the horizontal axis up to 48 weeks. The graph compares two groups with viral load levels less than 400 c/mL and less than 50 c/mL, illustrating patient response percentages over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.